<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>journalClub &#187; medico-legal</title>
	<atom:link href="http://www.journalclub.org/categories/medico-legal/feed" rel="self" type="application/rss+xml" />
	<link>http://www.journalclub.org</link>
	<description>Comments on the medical literature</description>
	<lastBuildDate>Wed, 21 Dec 2011 17:01:27 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.0.1</generator>
		<item>
		<title>Vioxx and the 140,000 MI&#8217;s</title>
		<link>http://www.journalclub.org/2005/01/25/n50</link>
		<comments>http://www.journalclub.org/2005/01/25/n50#comments</comments>
		<pubDate>Wed, 26 Jan 2005 03:49:22 +0000</pubDate>
		<dc:creator>mjmd</dc:creator>
				<category><![CDATA[cardiovascular]]></category>
		<category><![CDATA[medico-legal]]></category>

		<guid isPermaLink="false">http://www.journalclub.org/2005/01/25/n50</guid>
		<description><![CDATA[As I previously noted here, a study by Graham et al, examining the cardiovascular risks of Vioxx, was being considered for publication in the Lancet when it was prematurely published on the FDA&#8217;s website, much to the Lancet&#8217;s dismay. Today, that same study, with some modifications, has been published online at the Lancet. It is [...]]]></description>
		<wfw:commentRss>http://www.journalclub.org/2005/01/25/n50/feed</wfw:commentRss>
		<slash:comments>2</slash:comments>
		</item>
		<item>
		<title>Six articles on postmarketing drug surveillance from JAMA</title>
		<link>http://www.journalclub.org/2004/11/27/n26</link>
		<comments>http://www.journalclub.org/2004/11/27/n26#comments</comments>
		<pubDate>Sat, 27 Nov 2004 16:15:48 +0000</pubDate>
		<dc:creator>mjmd</dc:creator>
				<category><![CDATA[cardiovascular]]></category>
		<category><![CDATA[medico-legal]]></category>

		<guid isPermaLink="false">http://www.journalclub.org/2004/11/26/n26</guid>
		<description><![CDATA[The pharmaceutical industry and the FDA are being battered by testimony and discussion in the wake of Vioxx. Presumably this will soon die down: news stories appear, flare up and soon fizzle out when their energy (and the public&#8217;s interest) is spent. For now, however, the drug surveillance story is still burning bright. David Graham, [...]]]></description>
		<wfw:commentRss>http://www.journalclub.org/2004/11/27/n26/feed</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
		<item>
		<title>A new patent for an old drug in a new population</title>
		<link>http://www.journalclub.org/2004/11/10/n18</link>
		<comments>http://www.journalclub.org/2004/11/10/n18#comments</comments>
		<pubDate>Wed, 10 Nov 2004 04:56:30 +0000</pubDate>
		<dc:creator>mjmd</dc:creator>
				<category><![CDATA[cardiovascular]]></category>
		<category><![CDATA[medico-legal]]></category>

		<guid isPermaLink="false">http://www.journalclub.org/2004/11/10/n18</guid>
		<description><![CDATA[In a much discussed (see Kevin MD and Medical rants) study presented at the AHA meetings in New Orleans and just being published in this week&#8217;s NEJM, a fixed dose combination of hydralazine and isosorbide dinitrate, BiDil, was found to significantly reduce morbidity and mortality in African American patients with congestive heart failure. BiDil (vs [...]]]></description>
		<wfw:commentRss>http://www.journalclub.org/2004/11/10/n18/feed</wfw:commentRss>
		<slash:comments>2</slash:comments>
		</item>
		<item>
		<title>Medical decision-making competence</title>
		<link>http://www.journalclub.org/2004/10/19/n6</link>
		<comments>http://www.journalclub.org/2004/10/19/n6#comments</comments>
		<pubDate>Wed, 20 Oct 2004 02:36:03 +0000</pubDate>
		<dc:creator>mjmd</dc:creator>
				<category><![CDATA[medico-legal]]></category>
		<category><![CDATA[psychiatry]]></category>

		<guid isPermaLink="false">http://www.journalclub.org/2004/10/19/n6</guid>
		<description><![CDATA[This week&#8217;s Lancet contains a study by Raymont et al investigating the prevalence of mental incapacity in medical inpatients and associated risk factors (see also this item in Shrinkette&#8217;s blog ). In order to judge medical decision-making competence, the authors used two tools: the MacArthur competence assessment tool for treatment (MacCAT-T), and clinical vignettes (based [...]]]></description>
		<wfw:commentRss>http://www.journalclub.org/2004/10/19/n6/feed</wfw:commentRss>
		<slash:comments>2</slash:comments>
		</item>
	</channel>
</rss>

